Iheanacho, Ike http://orcid.org/0000-0002-1585-8099
Yoo, Hyun Kyoo
Yang, Xiaoqin
Dodman, Sophie
Hughes, Rachel
Amin, Suvina
Funding for this research was provided by:
Merck Sharp and Dohme
AstraZeneca
Article History
Received: 1 February 2021
Accepted: 28 May 2021
First Online: 18 June 2021
Declarations
:
: Not applicable: the study did not involve conducting research on humans, being based entirely on analysis of already published data, for which no ethics approval was needed.
: Not applicable: the study did not involve conducting research on humans, being based entirely on analysis of already published data, for which no consent for participation was needed.
: Not applicable: the study did not involve conducting research on humans, being based entirely on analysis of already published data, for which no consent for publication was needed.
: H.K.Y. and S.A. are employed by AstraZeneca and own stock. X.Y. is an employee of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, and owns stock in Merck & Co., Inc., Kenilworth, NJ, USA. I.I., S.D., and R.H. are employed by Evidera, which provides consulting and other research services to pharmaceutical, medical device, and related organizations. In their salaried positions, they work with a variety of companies and organizations and are precluded from receiving payment or honoraria directly from these organizations for services rendered. Evidera received funding from AstraZeneca and Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, to participate in the study and to provide medical writing support for dissemination of this manuscript. All authors participated in data analysis and interpretation and contributed to the development of the manuscript.
: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval to the version to be published.